TRABECTEDIN 1 mg Solution for Infusion (Trabec)

TRABECTEDIN 1 mg Solution for Infusion (Trabec)

$730.00 $355.00
Prescription Required

TRABECTEDIN 1 mg Solution for Infusion (Trabec) is a prescription chemotherapy medicine used to treat advanced soft tissue sarcoma and, in combination with other medicines, relapsed platinum-sensitive ovarian cancer. It is administered as an intravenous (IV) infusion under the supervision of an oncologist. Trabectedin helps slow the growth and spread of cancer cells by interfering with their DNA.

Generic name TRABECTEDIN
Strength 1 mg
Manufacturer Natco
Package size 1 Vial
Used for Advanced soft tissue sarcoma
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries.
Enquire via WhatsApp

Uses of TRABECTEDIN 1 mg

  • Treats advanced soft tissue sarcoma
  • Treats relapsed platinum-sensitive ovarian cancer as part of combination therapy
  • Helps slow cancer progression
  • May be used after certain previous treatments have stopped working
  • Supports long-term cancer management in suitable patients

Benefits of TRABECTEDIN

  • Targets the growth and division of cancer cells
  • May help delay disease progression
  • May improve treatment outcomes in suitable patients with advanced cancer
  • Can be combined with other anticancer medicines
  • Provides a treatment option when certain other therapies are no longer effective

How Does TRABECTEDIN 1 mg Work?

Trabectedin 1 mg works by binding to the DNA of cancer cells and disrupting processes involved in DNA function, repair, and cell division. This prevents cancer cells from growing and multiplying, which can lead to cancer-cell death and help slow tumour progression.

Side Effects

  • Fatigue
  • Nausea
  • Vomiting
  • Loss of appetite
  • Constipation
  • Low white blood cell count
  • Elevated liver enzyme levels
  • Infusion-site reactions

Precautions

  • Administer only under the supervision of an oncologist or trained healthcare professional.
  • Regular blood tests and liver function tests are required during treatment.
  • Inform your doctor if you have liver disease, kidney disease, muscle problems, or an active infection.
  • Tell your healthcare provider about all medicines and supplements you are taking to help prevent drug interactions.
  • Avoid pregnancy during treatment and use effective contraception as advised by your doctor.
  • Seek immediate medical attention if you develop fever, unusual bleeding, severe muscle pain, dark urine, or signs of infection.
  • Do not stop treatment or alter your treatment schedule without consulting your doctor.
Enquire via WhatsApp